Barclays’s AN2 Therapeutics ANTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-28,318
| Closed | -$92K | – | 4169 |
|
|
2024
Q1 | $92K | Sell |
28,318
-15,920
| -36% | -$51.7K | ﹤0.01% | 3668 |
|
|
2023
Q4 | $907K | Buy |
44,238
+41,068
| +1,296% | +$842K | ﹤0.01% | 2668 |
|
|
2023
Q3 | $51K | Sell |
3,170
-23,904
| -88% | -$385K | ﹤0.01% | 3585 |
|
|
2023
Q2 | $230K | Sell |
27,074
-5,699
| -17% | -$48.4K | ﹤0.01% | 3019 |
|
|
2023
Q1 | $323K | Buy |
32,773
+2,715
| +9% | +$26.8K | ﹤0.01% | 2901 |
|
|
2022
Q4 | $286K | Buy |
30,058
+2,780
| +10% | +$26.5K | ﹤0.01% | 2916 |
|
|
2022
Q3 | $475K | Buy |
27,278
+22,390
| +458% | +$390K | ﹤0.01% | 2621 |
|
|
2022
Q2 | $38K | Sell |
4,888
-13,332
| -73% | -$104K | ﹤0.01% | 3838 |
|
|
2022
Q1 | $275K | Buy |
+18,220
| New | +$275K | ﹤0.01% | 3134 |
|